ArticleOncology letters2019

Phenotype of mesenchymal stem cells from patients with myelodyplastic syndrome maybe partly modulated by decitabine.

Yanbin Pang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.